Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

Keyphrases

• Neurological Disorders 100%
• Therapeutic Outcome 100%
• Central Nervous System 100%
• Lipid Nanocarriers 100%
• Neurodegenerative Diseases 66%
• Blood-brain Barrier 66%
• Clinical Application 33%
• Clinical Practice 33%
• Alzheimer 33%
• Chronic Disease 33%
• Clinical Trials 33%
• Targeted Therapy 33%
• Advanced Disease 33%
• Dosage Forms 33%
• Barrier Function 33%
• Dementia 33%
• Lipid Carriers 33%
• Translational Development 33%
• Nanocarriers 33%
• Drug Discovery 33%
• Drug Research 33%
• Technological Progress 33%
• Successful Completion 33%
• Brain Drug Delivery 33%
• Formulation Approaches 33%
• Parkinson 33%
• Targeted Drug Therapy 33%
• Blood-brain Barrier Permeability 33%
• Market Authorization 33%
• Defection 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Neurologic Disease 100%
• Nanocarrier 100%
• Blood-Brain Barrier 75%
• Clinical Trial 25%
• Pharmacotherapy 25%
• Dosage Forms 25%
• Drug Discovery 25%